section name header

Basics ⬇

DESCRIPTION

EPIDEMIOLOGY

Incidence

The overall incidence of anthracycline-induced cardiomyopathy in the U.S. is ~2.2%.

RISK FACTORS

Genetics

Unknown.

GENERAL PREVENTION

PATHOPHYSIOLOGY

Anthracycline-induced myocardial necrosis is due to direct membrane lipid damage and local free radical production. Vasospasm can occur with 5-fluorouracil and other agents.

ETIOLOGY

Chemotherapeutic agent-induced myocardial and vascular inflammation, disease, and damage

COMMONLY ASSOCIATED CONDITIONS

Anemia

Diagnosis ⬆ ⬇

History

Physical Exam

DIAGNOSTIC TESTS & INTERPRETATION

Lab

CBC may show anemia.

Initial lab tests

EKG abnormalities are nonspecific and may be transient:

Imaging

Diagnostic Procedures/Surgery

Pathological Findings

Cardiac necrosis

DIFFERENTIAL DIAGNOSIS

Medication (Drugs) ⬆ ⬇

Treatment ⬆ ⬇

ADDITIONAL TREATMENT

General Measures

Referral

Symptoms of heart failure, signs of heart failure or LVEF < normal should occasion a cardiology consultation and follow-up.

Additional Therapies

Coenzyme Q10 has been used to protect the heart from toxicity, but there are no convincing studies to support it.

SURGERY

Selected patients who no longer have signs of malignancy may be candidates for cardiac transplantation, but the risks of immunosuppression-induced recurrence of malignancy must be weighed against the benefits of transplantation.

IN-PATIENT CONSIDERATIONS

Initial Stabilization

Appropriate treatment for heart failure, arrhythmias, or myocardial ischemia

Admission Criteria

Standard admission for acute heart failure, ischemia, or arrhythmia

Discharge Criteria

Resolution of symptoms of heart failure, ischemia, or arrhythmia

Ongoing Care ⬆ ⬇

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

DIET

Low salt

PATIENT EDUCATION

Continue cardiac medications and follow-up until problem resolved.

PROGNOSIS

COMPLICATIONS

Cardiac death, persistent heart failure

Miscellaneous ⬆ ⬇

CODES

ICD9

SNOMED

CLINICAL PEARLS

Reference(s) ⬆ ⬇

ADDITIONAL READING

Author(s) ⬆

Chintan S. Desai

Sanjiv J. Shah